Janney Montgomery Scott LLC acquired a new position in Parametric Equity Premium Income ETF (NYSEARCA:PAPI – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 26,322 shares of the company’s stock, valued at approximately $665,000. Janney Montgomery Scott LLC owned 0.30% of Parametric Equity Premium Income ETF as of its most recent filing with the Securities & Exchange Commission.
Separately, OLD Mission Capital LLC grew its holdings in shares of Parametric Equity Premium Income ETF by 80.9% during the first quarter. OLD Mission Capital LLC now owns 32,473 shares of the company’s stock worth $862,000 after buying an additional 14,526 shares in the last quarter.
Parametric Equity Premium Income ETF Stock Down 0.3%
Parametric Equity Premium Income ETF stock opened at $25.78 on Thursday. Parametric Equity Premium Income ETF has a 52-week low of $23.32 and a 52-week high of $28.46. The company has a fifty day simple moving average of $25.96 and a 200-day simple moving average of $25.60. The firm has a market capitalization of $252.64 million, a price-to-earnings ratio of 15.71 and a beta of 0.41.
About Parametric Equity Premium Income ETF
The Parametric Equity Premium Income ETF (PAPI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in a broad equity portfolio of US dividend payers, while utilizing a laddered, naked call writing strategy on the S&P 500. The fund seeks to provide monthly income and capital appreciation.
Further Reading
- Five stocks we like better than Parametric Equity Premium Income ETF
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Using the MarketBeat Dividend Yield Calculator
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Parametric Equity Premium Income ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parametric Equity Premium Income ETF and related companies with MarketBeat.com's FREE daily email newsletter.